TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine

被引:79
作者
Babiuk, S
Mookherjee, N
Pontarollo, R
Griebel, P
Littel-Van den Hurk, SV
Hecker, R
Babiuk, L
机构
[1] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
[2] Pyxis Genom Canada, Saskatoon, SK, Canada
[3] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada
[4] Qiagen GmbH, Hilden, Germany
关键词
CpG; DNA vaccine; gene expression; TLR9;
D O I
10.1111/j.1365-2567.2004.01938.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmid DNA continues to attract interest as a potential vaccine-delivery vehicle. However, the mechanisms whereby immune responses are elicited by plasmids are not fully understood. Although there have been suggestions regarding the importance of CpG motifs in plasmid immunogenicity, the molecular mechanisms by which CpG motifs enhance immune responses to DNA vaccines are not well understood. As Toll-like receptor 9-deficient (TLR9(-/-)) mice fail to respond to the adjuvant effects of CpG oligonucleotides, we used these mice to determine the effect of CpG motifs in plasmids used for DNA immunization. In the study described below, we report that DNA immunization was as effective in eliciting antigen-specific antibody and at stimulating antigen-specific interferon-gamma (IFN-gamma)-secreting cells in TLR9(-/-) mice as in TLR9(+/+) mice. This study illustrates that DNA vaccines elicit immune responses by multiple mechanisms and demonstrates that TLR9 is not essential for the induction of immune responses following DNA immunization.
引用
收藏
页码:114 / 120
页数:7
相关论文
共 29 条
[11]   Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs [J].
Krieg, AM ;
Wu, T ;
Weeratna, R ;
Efler, SM ;
Love-Homan, L ;
Yang, L ;
Yi, AK ;
Short, D ;
Davis, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12631-12636
[12]   The role of CpG dinucleotides in DNA vaccines [J].
Krieg, AM ;
Yi, AK ;
Schorr, J ;
Davis, HL .
TRENDS IN MICROBIOLOGY, 1998, 6 (01) :23-27
[13]   Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals [J].
Littel-van den Hurk, SV ;
Gerdts, V ;
Loehr, BI ;
Pontarollo, R ;
Rankin, R ;
Uwiera, R ;
Babiuk, LA .
ADVANCED DRUG DELIVERY REVIEWS, 2000, 43 (01) :13-28
[14]   EPITOPE SPECIFICITY OF THE PROTECTIVE IMMUNE-RESPONSE INDUCED BY INDIVIDUAL BOVINE HERPESVIRUS-1 GLYCOPROTEINS [J].
LITTELVANDENHURK, SV ;
GIFFORD, GA ;
BABIUK, LA .
VACCINE, 1990, 8 (04) :358-368
[15]   DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice [J].
Ma, XY ;
Forns, X ;
Gutierrez, R ;
Mushahwar, IK ;
Wu, T ;
Payette, PJ ;
Bukh, J ;
Purcell, RH ;
Davis, HL .
VACCINE, 2002, 20 (27-28) :3263-3271
[16]   First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response [J].
MacGregor, RR ;
Boyer, JD ;
Ugen, KE ;
Lacy, KE ;
Gluckman, SJ ;
Bagarazzi, ML ;
Chattergoon, MA ;
Baine, Y ;
Higgins, TJ ;
Ciccarelli, RB ;
Coney, LR ;
Ginsberg, RS ;
Weiner, DB .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :92-100
[17]   Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27 [J].
Manickan, E ;
Yu, ZY ;
Rouse, RJD ;
Wire, WS ;
Rouse, BT .
VIRAL IMMUNOLOGY, 1995, 8 (02) :53-61
[18]   Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors [J].
Pontarollo, RA ;
Babiuk, LA ;
Hecker, R ;
Littel-van den Hurk, SV .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :2973-2981
[19]   Immunostimulatory DNA sequences necessary for effective intradermal gene immunization [J].
Sato, Y ;
Roman, M ;
Tighe, H ;
Lee, D ;
Corr, M ;
Nguyen, MD ;
Silverman, GJ ;
Lotz, M ;
Carson, DA ;
Raz, E .
SCIENCE, 1996, 273 (5273) :352-354
[20]   Vaccination with plasmid DNA activates dendritic cells via toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice [J].
Spies, B ;
Hochrein, H ;
Vabulas, M ;
Huster, K ;
Busch, DH ;
Schmitz, F ;
Heit, A ;
Wagner, H .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5908-5912